LOMA NEGRA CIA IND-SPON ADR (LOMA)

US54150E1047 - ADR

10.41  -0.62 (-5.62%)

After market: 10.58 +0.17 (+1.63%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LOMA. LOMA was compared to 12 industry peers in the Construction Materials industry. LOMA has a medium profitability rating, but doesn't score so well on its financial health evaluation. LOMA is valied quite expensively at the moment, while it does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

In the past 5 years LOMA has always been profitable.
Each year in the past 5 years LOMA had a positive operating cash flow.

1.2 Ratios

LOMA has a Return On Assets (7.61%) which is comparable to the rest of the industry.
LOMA has a Return On Equity of 14.21%. This is comparable to the rest of the industry: LOMA outperforms 50.00% of its industry peers.
The Return On Invested Capital of LOMA (6.81%) is worse than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LOMA is in line with the industry average of 10.78%.
The 3 year average ROIC (12.31%) for LOMA is well above the current ROIC(6.81%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.61%
ROE 14.21%
ROIC 6.81%
ROA(3y)2.95%
ROA(5y)6.35%
ROE(3y)4.76%
ROE(5y)10.72%
ROIC(3y)12.31%
ROIC(5y)12.46%

1.3 Margins

LOMA has a better Profit Margin (15.75%) than 75.00% of its industry peers.
LOMA's Profit Margin has declined in the last couple of years.
LOMA has a Operating Margin (14.92%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of LOMA has declined.
LOMA has a worse Gross Margin (25.48%) than 66.67% of its industry peers.
LOMA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.92%
PM (TTM) 15.75%
GM 25.48%
OM growth 3Y-10.79%
OM growth 5Y-3.06%
PM growth 3Y-55.27%
PM growth 5Y-18.32%
GM growth 3Y-6.06%
GM growth 5Y-0.29%

3

2. Health

2.1 Basic Checks

LOMA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for LOMA has been reduced compared to 5 years ago.
The debt/assets ratio for LOMA is higher compared to a year ago.

2.2 Solvency

A Debt/Equity ratio of 0.20 indicates that LOMA is not too dependend on debt financing.
The Debt to Equity ratio of LOMA (0.20) is better than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LOMA has a Current Ratio of 1.22. This is a normal value and indicates that LOMA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of LOMA (1.22) is worse than 75.00% of its industry peers.
LOMA has a Quick Ratio of 1.22. This is a bad value and indicates that LOMA is not financially healthy enough and could expect problems in meeting its short term obligations.
LOMA has a worse Quick ratio (0.35) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.35

5

3. Growth

3.1 Past

LOMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 251.73%, which is quite impressive.
LOMA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.62% yearly.
Looking at the last year, LOMA shows a very strong growth in Revenue. The Revenue has grown by 104.19%.
LOMA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.23% yearly.
EPS 1Y (TTM)251.73%
EPS 3Y202.18%
EPS 5Y30.62%
EPS Q2Q%97.85%
Revenue 1Y (TTM)104.19%
Revenue growth 3Y88.7%
Revenue growth 5Y59.23%
Sales Q2Q%116.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y8.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LOMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LOMA NEGRA CIA IND-SPON ADR

NYSE:LOMA (11/21/2024, 8:04:00 PM)

After market: 10.58 +0.17 (+1.63%)

10.41

-0.62 (-5.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.21B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.61%
ROE 14.21%
ROCE
ROIC
ROICexc
ROICexgc
OM 14.92%
PM (TTM) 15.75%
GM 25.48%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.22
Quick Ratio 0.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)251.73%
EPS 3Y202.18%
EPS 5Y
EPS Q2Q%
EPS Next Y8.44%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)104.19%
Revenue growth 3Y88.7%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y